Jim Simons acquired 98.6k Bolt Biotherapeutics shares worth $639k. That's 0.00% of their equity portfolio (2339th largest holding). The investor owns 5.03% of the outstanding Bolt Biotherapeutics stock. The first Bolt Biotherapeutics trade was made in Q2 2021. Since then Jim Simons bought shares seventeen more times and sold shares on three occasions. The stake costed the investor $460k, netting the investor a gain of 39% so far.